ORG Wealth Partners LLC Makes New $251,000 Investment in The Clorox Company (NYSE:CLX)

ORG Wealth Partners LLC purchased a new position in The Clorox Company (NYSE:CLX) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,538 shares of the company’s stock, valued at approximately $251,000.

A number of other hedge funds also recently modified their holdings of CLX. Van ECK Associates Corp lifted its position in Clorox by 1,715.5% in the 2nd quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock valued at $199,411,000 after acquiring an additional 1,380,724 shares in the last quarter. Nuance Investments LLC lifted its holdings in shares of Clorox by 150.6% in the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after purchasing an additional 960,094 shares in the last quarter. Confluence Investment Management LLC acquired a new position in shares of Clorox during the first quarter worth about $135,630,000. Wulff Hansen & CO. grew its holdings in shares of Clorox by 13,547.0% during the second quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock worth $60,063,000 after buying an additional 436,891 shares in the last quarter. Finally, Acadian Asset Management LLC raised its position in Clorox by 26.5% in the 1st quarter. Acadian Asset Management LLC now owns 882,526 shares of the company’s stock valued at $135,099,000 after buying an additional 184,847 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. JPMorgan Chase & Co. raised their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. Wells Fargo & Company cut their price target on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft raised their price objective on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, DA Davidson reissued a “neutral” rating and set a $153.00 price target on shares of Clorox in a research report on Friday, September 6th. Six analysts have rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $150.14.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.51% of the stock is currently owned by corporate insiders.

Clorox Stock Performance

Shares of CLX stock opened at $161.27 on Monday. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.09. The company has a market capitalization of $20.03 billion, a price-to-earnings ratio of 83.06, a PEG ratio of 3.19 and a beta of 0.41. The company has a 50-day simple moving average of $157.36 and a 200 day simple moving average of $144.72. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.54 by $0.28. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. On average, sell-side analysts predict that The Clorox Company will post 6.64 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.03%. Clorox’s payout ratio is presently 252.85%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.